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acid in human plasma.[4]
A  new  HPLC  method  for  the  determination  of 
5-aminosalicylic acid (5-ASA) and N-acetyl-5-aminosalicylic 
acid (N-Ac-5-ASA) in human plasma was developed 
and validated. The plasma samples were analyzed after 
protein precipitation with methanol and the two analytes 
were separated using a C18 column, with the mobile 
phase composed of 17.5 mmol/L acetic acid (pH 3.3) : 
acetonitrile = 85:15 (v/v) at 0.2 mL/min flow rate. 4-ASA 
and N-Ac-4-ASA were used as internal standards. Selective 
detection was performed by tandem mass spectrometry 
with electrospray source, operating in negative ionization 
mode, and in multiple reaction monitoring acquisition (m/z 
152-->108 for 5-ASA; m/z 194-->150 and 194-->107 
for N-Ac-5-ASA). The method was applied to evaluate 
the pharmacokinetics of 5-ASA after a single oral dose 
administration of this compound (1200 mg) to 24 healthy 
volunteers. The mean maximum concentration levels were 
INTRODUCTION
Mesalamine is chemically, 5-amino-2-hydroxybenzoic acid, 
which is used as a gastrointestinal anti-inflammatory drug for 
the treatment of inflammatory bowel diseases[1] and active 
ulcerative proctitis.[2,3] It is not official in any pharmacopoeia. 
The literature shows that mass spectroscopy[4] and 
high performance liquid chromatography[5] (HPLC) 
have been reported for determination of mesalamine. 
Spectrophotometric analytical reports are not found for 
its quantitative estimation in bulk drug and tablet dosage 
forms in literature. In the present study, new, simple, and 
selective UV Spectrophotometric methods were elaborated 
for the determination of mesalamine in commercial dosage 
forms.
Development and validation of a HPLC-ESI-MS/MS 
method for the determination of 5-aminosalicylic acid 
and its major metabolite N-acetyl-5-aminosalicylic 
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Three simple and sensitive visible spectrophotometric methods (A, B, and C) have been developed for the 
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680 ng/mL for 5-ASA and 1240 ng/mL for N-Ac-5-ASA, 
and the kinetic profiles were in agreement with previous 
studies.
High-performance  liquid-chromatographic 
determination of  5-aminosalicylic acid and its 
metabolites in blood plasma.[5]
A new HPLC bioanalytical method for the determination 
of 5-ASA and its metabolites in blood plasma was 
developed and validated. The sample preparation step 
consisted of the deproteination of plasma by HClO(4) 
and the above-mentioned derivatization of ASAs, followed 
by liquid–liquid extraction of all N-acyl-ASA-derivatives. 
Chromatographic analyses were performed on a 250 – 4 
mm column containing Purospher RP-18 e, 5 microm 
(Merck, Darmstadt, Germany) with a precolumn (4 – 4 
mm). The column effluent was monitored using both UV 
photodiode-array (lambda = 313 nm) and fluorescence 
detectors (lambda (exc.) = 300 nm / lambda(emiss.) = 406 
nm) in tandem. The identity of individual N-acyl-ASAs in 
the extracts from biometrics was verified by characteristic 
UV-spectra and by HPLC / MS experiments. The whole 
analysis lasted for 23 minutes at a flow rate of 1 ml min 
(-1). LLOQ (LOD) was estimated at 126 (20) pmol ml (-1) 
of plasma for N-acetyl-5-ASA and 318 (50) pmol ml (-1) 
of plasma for N-propionyl-5-ASA. The validated HPLC 
method was applied to the pharmacokinetic studies of 
mesalazine in humans and animals.
MATERIALS AND METHODS
Three simple and sensitive visible spectrophotometric 
methods (A, B, and C) have been developed for the 
quantitative estimation of mesalamine by using Bratton-
Marshall reagent (BMR), paradimethylaminobenzaldehyde 
(PDAB), and Gibb’s reagent at room temperature.
Method A 
It is based on Diazotization of Mesalamine (1) with 
nitrous acid, to form diazotized Mesalamine (2), followed 
by its coupling with N-(1-naphthyl) ethylene-diamine 
dihydrochloride [Bratton-Marshall reagent] (3) to form a 
violet colored chromogen (4) with maximum absorption at 
552 nm; it obeyed the Beer’s law in the concentration range 
of 2 – 30 µg/ml. The reaction mechanism for method A 
is shown in [Figure 1].
Method B 
It is based on the condensation of Mesalamine (1) with 
p-dimethylaminobenzaldeyde (5) to form the Schiff’s 
base (6) that is a yellow colored chromogen and shows 
maximum absorbance at 440 nm; The Beer’s law is obeyed 
in the concentration range of 50 – 500µg/ml. The reaction 
mechanism for method B is shown in [Figure 2].
Method C 
Mesalamine (1) has a phenolic group when made to react 
with Gibb’s reagent (12), in alkaline pH it forms a colored 
chromogen (13), exhibiting absorption maximum at 494 
nm, and Beer’s law is obeyed in the concentration range 
of 5 – 60 µg/ml. The reaction mechanism for method C 
is shown in [Figure 3].
Spectrophotometric parameters are established for the 
standardization of the methods including statistical 
analysis of the data. These methods have been successfully 
extended to tablets containing mesalamine.
A Shimadzu UV / Visible double beam spectrophotometer 
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(model 1700), with 1 cm-matched quartz cells, was used 
for all spectral measurements. Scanning range of 190 – 
380nm for UV range and 380 – 800nm for visible range 
were used. All chemicals used were of A.R. grade from S.D. 
Fine Chemicals, Mumbai. Mesalamine was kindly gifted by 
Sun Pharma Ltd, Dadra.
Mesalamine equivalent to 100 mg was weighed accurately 
and dissolved in 2 ml of concentrated HCl in a 100 ml 
volumetric flask, and diluted up to the mark with water (1 
mg/ml) for visible spectrophotometric determination of 
mesalamine, using BMR (0.2%), HCL (2N), sodium nitrite 
(0.3%), and ammonium sulfamate (0.1%).
Twenty tablets of mesalamine were weighed and powdered. 
Powder equivalent to 100 mg mesalamine was weighed 
and mixed with 2 ml of concentrated HCl and 75 ml of 
distilled water. The mixture was shaken occasionally and 
filtered through Whatman No.41 filter paper. The residue 
was washed thoroughly with water. The filtrate and the 
washing were combined and the final dilution was brought 
up to the 100 ml mark in a 100 ml volumetric flask with 
distilled water. In case of formulation, one brand of 
commercially available tablets (Mesacol) was analyzed by 
the proposed methods. 
PROCEDURE
Method A
Aliquots of standard solution of mesalamine ranging 
from 0.5 – 3 ml (1 ml = 100 µg) were transferred into a 
series of 10 ml volumetric flasks. To each flask, 1.0 ml 
of hydrochloric acid (2 N) and 1.0 ml of sodium nitrite 
(0.3% w/v) were added and a reaction time of 10 minutes 
at 0 – 5°C was given for completion of the reaction. Next, 
1.0 ml of ammonium sulfamate (0.1% w/v) was added 
to each flask with gentle shaking and after 1 minute, 1 ml 
of BMR reagent (0.2%w/v) was added, and kept for 20 
minutes. Finally the volume in each flask was brought up 
to the 10 ml mark with distilled water. The absorbances of 
violet-colored chromogen were measured at 552 nm against 
the reagent blank Figure 4. The colored chromogen was 
stable for one hour. The amount of mesalamine present 
in the sample solution was computed from the respective 
calibration curve.
Method B
Aliquots of standard solution of mesalamine ranging 
from 0.5 to 5 ml (1 ml = 1000 µg) were transferred into 
a series of 10 ml volumetric flasks. To each flask, 2 ml 
of ethanolic PDAB and 1 ml of nitric acid (4 N) were 
added. The solutions were warmed on a water bath for 10 
minutes at 60 – 70°C. The resulting solutions were cooled 
to room temperature and the volume was brought up to 
the mark with water. The absorbances of the light yellow 
colored chromogen were measured at 440 nm against the 
reagent blank Figure 5. The colored chromogen was stable 
for three hours. The amount of mesalamine present in 
the sample solution was computed from the respective 
calibration curve.
Method C 
Aliquots of standard solution of mesalamine ranging from 
0.5 – 6 ml (1 ml = 100 µg) were transferred into a series 
of 10 ml volumetric flasks. To each flask, 0.5 ml of Gibb’s 
reagent (0.2%w/v in ethanol) and 1.0 ml of sodium nitrite 
(0.5% w/v) was added. The volume in each flask was 
brought up to 10 ml with distilled water. The absorbances 
of colored chromogen were measured at 494 nm against 
the reagent blank Figure 6. The colored chromogen was 
stable for eight hours. The amount of mesalamine present 
in the sample solution was computed from the respective 
calibration curve. 
The optical characteristics such as absorption maxima, 
Beer's law limits, molar absorptivity, and Sandell's sensitivity 
are presented in [Table 1]. The regression analysis using the 
method of least squares was performed for the slope (b), 
intercept (a), and correlation (r) obtained from different 
concentrations and the results are summarized in [Table 1]. 
The percentage relative standard deviation and percentage 
of error (0.05 and 0.01 level of confidence limit) were 
calculated from the mean of eight determinations. Beer's 
law limits of mesalamine are given in [Table 1]. The results 
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Table 1: Optical Characteristics and Precision
Parameters BMR PDAB Gibbs
Xmv (nm) 552 440 494
Beer's law limits 2-30 50-500 May-60
(µg/ml) (C)
Molar absoiptivity (L mol-1 cm-1) 6.237x102 3.744x102 1.959x103
Sandell's sensitivity (µg/cm2-0.001 
absorbance unit)
0.0249 0.415 0.007
Regression equation (Y*) 
Slope (b)
0.0391 0.0237 0.0168
Intercept (a) 0.0003 0.0041 0.0074
Correlation coefficient(r)  0.997 0.998 0.9988
% RSD 0.0012 0.00436 0.143
Range of errors** 0.00038 0.0017 0.0006
Confidence limits with 0.05 level
Confidence limits with 0.01 level 0.00056 0.0026 0.0009
Limit of detection 0.04 0.699 0.1712
Limit of quantitation 0.116 1.84 0.4505
Figure 5: Absorption Spectrum of Mesalamine with PDAB reagent
Figure 6: Absorption Spectrum of Mesalamine with Gibb’s reagent
Figure 4: Absorption Spectrum of Mesalamine with Bratton-Marshall 
reagent
showed that these methods had reasonable precision. 
Comparison of the results obtained with the proposed and 
UV methods for the dosage forms [Table 2] confirmed 
the suitability of the methods for pharmaceutical dosage 
forms when compared with the UV method. The proposed 
methods were reaction-specific and eliminated interference 
from impurities. The optimum conditions for color 
development for methods A, B, and C were established 
by varying the parameters one at a time, keeping the other 
parameters fixed, observing the effects of the product on 
the absorbance of the colored species, and incorporating 
them in the procedures. 
To evaluate the validity and reproducibility of the methods, 
known amounts of the pure drug were added to the 
previously analyzed pharmaceutical preparations and the 
mixtures were analyzed by the proposed methods. The 
percent recoveries are given in [Table 2]. Interference 
studies revealed that the common excipients and other 
additives such as lactose, starch, gelatin, talc, and magnesium 
trisilicate did not interfere at their regularly added levels.
RESULT 
Three new, sensitive and most economical analytical 
colorimetric methods were developed for the estimation 
of Mesalamine in bulk and pharmaceutical dosage forms. 
These methods are validated in terms of sensitivity, 
accuracy, and precision. The results were found to be 
accurate, and free from the interference of tablet excipients. 
The active pharmaceutical ingredient was extracted from 
its completed dosage form using hot water and HCl. The 
% recovery, linearity, and range, LOD and LOQ, Sandell’s 
sensitivity and molar absorptivity for mesalamine are 
summarized in [Tables 1 and 2]. The reaction mechanisms 
for all methods are shown in Figures 1-3.
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Table 2: Evaluation of Mesalamine in Pharmaceutical 
Preparations
Sample 
(Tablet)
Labelled 
amount (mg)
Amount obtained* (mg) Percentage 
recovery** Proposed 
method
Reference 
method
BMR UV BMR
Tt 400 398.14±0.02 399.58±0.02 99.49±A.05
PDAB uv PDAB
Tt 400 399.92±0.02 399.58±0.02 99.46±.03
Gibb's UV Gibb'
Tt 400 399.92±0.02 399.58±0.02 99.46±0.03
*Average of five determinations, ** Mean and Standard deviation of eight 
determinations (100 mg of Mesalamine was added and recovered)
CONCLUSION
The UV spectroscopic methods and colorimetric methods 
demonstrated herein, are applicable to the estimation of 
Mesalamine in the pure as well as the existing dosage 
forms. In order to ensure that the data is generated, the 
above-mentioned methods would prove both accurate 
and precise. The experiments have been performed on 
calibrated equipments using suitable reference standards. 
To prove and document their reliability, the methods have 
been carried out to a possible extent. The results expressed 
in [Tables 1 and 2] are for Spectrophotometric methods. 
In addition to the positive requirements for analytical 
methods, the striking advantage of all the presently 
developed methods is that they are economical. 
The proposed methods are found to be simple, sensitive, 
selective, accurate, precise, and economical, and can be used 
in the determination of mesalamine in bulk drug and its 
pharmaceutical dosage forms (tablets) in a routine manner. 
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